Table 2.
Dose Levels (mg/m2/dose)a | Treated Patients | Evaluable Patients | Patients With DLTs | ||
---|---|---|---|---|---|
Ribociclib | Everolimus | ||||
Level 1 | 120 | 1.2 | 3 | 3 | 0 |
Level 2 | 170 | 1.2 | 3 | 3 | 0 |
Level 3 | 170 | 1.5 | 7 | 6 | 1b |
Level 3, expansion cohort | 170 | 1.5 | 6 | 6 | 0 |
Abbreviation: DLT, dose-limiting toxicities.
aRibociclib administered on days 1-21; everolimus on days 1-28, cycle 1.
bGrade 3 lung infection.